IRIS
PASCALE, Rosa Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.752
AS - Asia 4.633
EU - Europa 2.933
SA - Sud America 2.341
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 157
OC - Oceania 16
Totale 18.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.464
BR - Brasile 2.072
SG - Singapore 1.852
CN - Cina 1.452
UA - Ucraina 828
IT - Italia 524
DE - Germania 374
HK - Hong Kong 321
VN - Vietnam 303
SE - Svezia 301
FR - Francia 256
GB - Regno Unito 179
FI - Finlandia 154
TR - Turchia 134
CA - Canada 117
IN - India 85
IQ - Iraq 80
AR - Argentina 74
BD - Bangladesh 65
MX - Messico 61
CZ - Repubblica Ceca 56
ZA - Sudafrica 50
RU - Federazione Russa 49
UZ - Uzbekistan 42
VE - Venezuela 42
PK - Pakistan 41
BE - Belgio 40
EC - Ecuador 40
CO - Colombia 36
ID - Indonesia 35
MA - Marocco 30
ES - Italia 28
JP - Giappone 28
AT - Austria 26
KR - Corea 22
AE - Emirati Arabi Uniti 21
PL - Polonia 21
PY - Paraguay 21
IR - Iran 20
LT - Lituania 20
JO - Giordania 19
HN - Honduras 17
CL - Cile 16
SA - Arabia Saudita 15
TN - Tunisia 15
AU - Australia 14
CR - Costa Rica 14
JM - Giamaica 14
UY - Uruguay 14
AZ - Azerbaigian 13
PE - Perù 13
NL - Olanda 12
SN - Senegal 12
SV - El Salvador 12
BO - Bolivia 11
EU - Europa 11
KE - Kenya 11
NP - Nepal 11
PA - Panama 11
GT - Guatemala 10
NI - Nicaragua 10
DZ - Algeria 9
BG - Bulgaria 8
IL - Israele 8
OM - Oman 8
PH - Filippine 8
PR - Porto Rico 8
CH - Svizzera 7
MY - Malesia 7
RO - Romania 7
EE - Estonia 6
EG - Egitto 6
KZ - Kazakistan 6
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
PT - Portogallo 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AO - Angola 4
KG - Kirghizistan 4
NG - Nigeria 4
PS - Palestinian Territory 4
TH - Thailandia 4
AL - Albania 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CG - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
GE - Georgia 3
GP - Guadalupe 3
LB - Libano 3
QA - Qatar 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BN - Brunei Darussalam 2
BW - Botswana 2
Totale 18.822
Salva come PNG Salva come JPEG
Città #
Dallas 2.039
Singapore 1.052
Chandler 955
San Jose 602
Jacksonville 489
Ashburn 476
Council Bluffs 339
Hong Kong 316
Beijing 292
Princeton 273
Santa Clara 217
Dearborn 201
Nanjing 198
Columbus 176
Ann Arbor 165
São Paulo 152
Wilmington 138
Sassari 128
Lauterbourg 126
Los Angeles 117
Ho Chi Minh City 110
Nanchang 101
Shanghai 98
Boardman 90
Rio de Janeiro 83
Milan 79
Hanoi 78
Izmir 76
New York 62
Tianjin 56
Changsha 53
Woodbridge 53
Shenyang 52
Brno 47
Belo Horizonte 46
Munich 41
Brussels 40
The Dalles 40
Toronto 40
Tashkent 39
Hebei 38
Jinan 38
Baghdad 36
Orem 35
Brasília 33
Jiaxing 32
Norwalk 30
Brooklyn 29
Falls Church 29
London 29
Campinas 27
Helsinki 27
Tokyo 27
Zhengzhou 27
Miano 26
Porto Alegre 26
San Francisco 26
Buffalo 25
Hangzhou 25
Atlanta 24
Guangzhou 24
Johannesburg 24
Ningbo 24
Chennai 22
Mountain View 22
Nuremberg 22
Boston 21
Curitiba 21
Denver 21
Montreal 21
Ribeirão Preto 21
Seoul 21
Rome 20
Warsaw 20
Andover 19
Amman 18
Augusta 18
Goiânia 18
Guarulhos 18
Kunming 18
Stockholm 18
Frankfurt am Main 17
Houston 17
Salvador 17
San Mateo 17
Washington 17
Chicago 16
Leawood 16
Mexico City 16
Phoenix 16
Fortaleza 15
Guayaquil 15
Praia Grande 15
Santo André 15
Ardabil 14
Dhaka 14
Mumbai 14
Ankara 13
Aracaju 13
Baku 13
Totale 11.045
Salva come PNG Salva come JPEG
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 362
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 254
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 229
1-5-formyltetrahydrofolate and 1-5-methyltetrahydrofolate rescue in L-1210 leukemia treated with high methotrexate doses 229
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 221
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 215
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 209
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 204
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 200
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 199
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosomine in the resistant BFF1 rat strain 199
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 197
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 190
Chemoprevention of hepatocarcinogenesis: S.adenosyl-L-methionine 190
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 188
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 186
Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 183
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 181
An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling 181
Amplification of c-myc oncogene in preneoplastic e neoplastic lesions induced in rat liver by the resistant hepatocyte protocol 173
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 172
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 171
Experimental models to define the genetic predisposition to liver cancer 171
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 169
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 168
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 167
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 167
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 166
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 165
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 164
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 163
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma 162
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 161
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 161
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 161
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 160
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 157
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 156
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 155
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 155
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 154
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 154
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 153
New insights on the role of epigenetic alterations in hepatocellular carcinoma 153
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 150
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 150
Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report 150
Alterations of methionine metabolism as potential targets for the prevention and therapy of hepatocellular carcinoma 150
Blood cell count indexes of systemic inflammation in carotid artery disease: current evidence and future perspectives 148
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 146
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 144
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 144
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 142
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 142
Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats 142
S-Adenosylmethionine Regulates Apurinic/Apyrimidinic Endonuclease 1 Stability: Implication in Hepatocarcinogenesis 140
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 140
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 139
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 139
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers 139
THE BN RAT STRAIN CARRIES DOMINANT HEPATOCARCINOGEN RESISTANCE LOCI 138
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 137
Genetic Control of Resistance to Hepatocarcinogenesis by the Mouse Hpcr3 Locus 135
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 134
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 133
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma? 132
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 132
Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene. 131
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 129
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma 128
Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. 128
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts. 126
Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats 126
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 124
Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System 123
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 122
The warburg effect 97 years after its discovery 122
GENETIC AND EPIGENETIC CONTROL OF MOLECULAR ALTERATIONS IN HEPATOCELLULAR CARCINOMA 121
S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. 121
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 120
Sulfatase 1: A new Jekyll and Hyde in hepatocellular carcinoma? 119
the role of S-adenosylmethionine in the regulation of glutathione pool and acetaldehyde production in acute ethanolintoxication 118
New putative prognostic markers and therapeutic targets for the molecular approach to treatment of hepatocellular carcinoma 117
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 116
Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? 116
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 116
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 115
Decreased stimulation by 12-O-tetradecanoylphorbol-13-acetate of superoxide radical production by polymorphonuclear leukocytes carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 114
Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation. 114
Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats 112
Role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholine by hepatocytes isolated from choline-deficient rats. 111
Modulation of P16INK4 activity by HSP90, Cdc37 and CRM1 influences the progression of preneoplastico lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 111
Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma. 111
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 110
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 108
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 107
Mapping a sex-hormone sensitive gene determining female resistance to liver carcinogenesis in a congenic F344 BN-Hcs4 rat. 107
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 106
Instabilità genomica nel carcinoma mammario 105
Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma 105
Totale 15.180
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022654 0 0 0 11 24 33 45 46 73 42 84 296
2022/20231.658 179 147 43 293 152 279 0 189 278 6 57 35
2023/2024390 89 27 13 16 54 15 0 14 0 3 53 106
2024/20254.323 30 39 223 120 204 149 323 745 1.433 686 258 113
2025/20266.299 314 1.541 951 767 554 380 790 187 261 339 165 50
2026/20271.889 187 432 503 767 0 0 0 0 0 0 0 0
Totale 18.992